Simufilam in Alzheimer’s Disease: Assessment of Efficacy of a Controversial Drug in Human Neuronal Cell CultureAnkita Srivastava(Long Island University), Allison B. Reiss(Biomedical Research Institute)PharmaceuticalsFebruary 7, 202610.3390/ph19020281Cited by 0SaveCiteExport RISWatch citationsRelated PapersTherapeutic Potential of P110 Peptide: New Insights into Treatment of Alzheimer’s Disease|Life|2023|12Hydroxychloroquine Effects on THP-1 Macrophage Cholesterol Handling: Cell Culture Studies Corresponding to the TARGET Cardiovascular Trial|Medicina|2022|1